Résultats de la recherche - 188 results
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
estimate, between February and March 2023, the first booster (mostly administered >24 weeks) showed little to no added protection: rVE estimates ranged between-13–17%, among the different age groups. VE ...
Couverture vaccinale et impact épidémiologique de la campagne de vaccination COVID-19 chez les personnes présentant des maladies sous-jacentes en Belgique
sous-jacentes, la vaccination contre la COVID-19 offre une protection contre une hospitalisation et une admission en USI. Par exemple, au cours de la période de dominance du variant Omicron, la protection initiale ...
Surmortalité durant la 1re et 2e vague de l'épidémie de COVID-19 en Belgique
absence de mise en œuvre de mesures contraignantes (par exemple, la distanciation sociale, etc.) et d’interventions non pharmaceutiques (par exemple, l’hygiène des mains, les équipements de protection ...
Excess mortality during the first and second waves of the COVID-19 epidemic in Belgium
distancing, etc.) and non-pharmaceutical interventions (e.g., hand hygiene, personal protective equipment, etc.), it is possible that the excess mortality during this period would have been greater. Mortality ...
Resultaten van de 6e nationale campagne ter bevordering van de handhygiëne in ziekenhuizen, 2014-2015
contact’ and ‘exposure to body fluids’, compared to ‘before patient contact’, implying that healthcare workers consistently tend to protect themselves more or less than to protect the patient, as earlier ...
Cytokine and immunoglobulin isotype profiles during CP7_E2alf vaccination against a challenge with the highly virulent Koslov strain of classical swine fever virus.
Vaccination Vaccines, Attenuated Viral Vaccines Abstract: CP7_E2alf is a promising marker vaccine candidate against classical swine fever (CSF). To better understand the mechanisms of protection, cytokine and ...
Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.
usually carried out using highly virulent CSFV strains of genotype 1 that do not mirror the current field situation where strains of genotype 2 predominate. To prove that CP7_E2alf also protects against ...
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.
HPV-based versus cytology-based screening for prevention of invasive cancer in women who undergo regular screening, of modifiers (eg, age) of this relative efficacy, and of the duration of protection. We did ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors (Protocol)
of prophylactic HPV vaccines in females. The assessment of clinical efficacy will address protection against HPV infection (for homologous and heterologous HPV types), against re-infection, against ...
Infectious Bursal Disease: a complex host-pathogen interaction.
immunosuppression in the field situation. Although satisfactory protection may be provided by the induction of high neutralizing antibody titres, interference from parental antibodies with vaccination has become the ...